| ［1］ |
Pundir S, Gridneva Z, Pillai A, et al. Human milk glucocorticoid levels are associated with infant adiposity and head circumference over the first year of life［J］. Front Nutr, 2020,7:166. doi: 10.3389/fnut.2020.00166.
|
| ［2］ |
Rademaker M, Agnew K, Andrews M, et al. Psoriasis in those planning a family, pregnant or breast⁃feeding. The Australasian Psoriasis Collaboration［J］. Australas J Dermatol, 2018,59（2）:86⁃100. doi: 10.1111/ajd.12641.
|
| ［3］ |
Kushner CJ, Concha J, Werth VP. Treatment of autoimmune bullous disorders in pregnancy［J］. Am J Clin Dermatol, 2018,19（3）:391⁃403. doi: 10.1007/s40257⁃018⁃0342⁃0.
|
| ［4］ |
Lee KM, Kim YS, Seo GS, et al. Use of thiopurines in inflammatory bowel disease: a consensus statement by the Korean association for the study of intestinal diseases （KASID）［J］. Intest Res, 2015,13（3）:193⁃207. doi: 10.5217/ir.2015.13. 3.193.
|
| ［5］ |
Patsatsi A, Marinovic B, Murrell D. Autoimmune bullous diseases during pregnancy: solving common and uncommon issues［J］. Int J Womens Dermatol, 2019,5（3）:166⁃170. doi: 10.1016/j.ijwd. 2019.01.003.
|
| ［6］ |
Tavakolpour S, Mirsafaei HS, Delshad S. Management of pemphigus disease in pregnancy［J］. Am J Reprod Immunol, 2017,77（1）. doi: 10.1111/aji.12601.
|
| ［7］ |
Hoffmann F, Kraft A, Heigl F, et al. Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica: therapy option for acute relapses during pregnancy and breastfeeding［J］. Nervenarzt, 2015,86（2）:179⁃186. doi: 10.1007/ s00115⁃014⁃4239⁃8.
|
| ［8］ |
Wan J, Imadojemu S, Werth VP. Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum［J］. Clin Dermatol, 2016,34（3）:344⁃352. doi: 10.1016/j.clindermatol. 2016.02.006.
|
| ［9］ |
Chi CC, Wang SH, Kirtschig G. Safety of topical corticosteroids in pregnancy［J］. JAMA Dermatol, 2016,152（8）:934⁃935. doi: 10.1001/jamadermatol.2016.1009.
|
| ［10］ |
Chi CC, Kirtschig G, Aberer W, et al. Updated evidence⁃based （S2e） European Dermatology Forum guideline on topical corticosteroids in pregnancy［J］. J Eur Acad Dermatol Venereol, 2017,31（5）:761⁃773. doi: 10.1111/jdv.14101.
|
| ［11］ |
Zhao CY, Chiang YZ, Murrell DF. Neonatal autoimmune blistering disease: a systematic review［J］. Pediatr Dermatol, 2016,33（4）:367⁃374. doi: 10.1111/pde.12859.
|
| ［12］ |
Pawar M, Singh M. Systemic steroids and risk of fecal⁃oral shedding and increased transmission of SARS⁃CoV⁃2 in pemphigus cases［J］. Clin Dermatol, 2020,38（6）:750⁃756. doi: 10.1016/j.clindermatol.2020.06.006.
|
| ［13］ |
Campanati A, Brisigotti V, Diotallevi F, et al. Active implications for dermatologists in ′SARS⁃CoV⁃2 ERA′: personal experience and review of literature［J］. J Eur Acad Dermatol Venereol, 2020，34（8）:1626⁃1632. doi: 10.1111/jdv.16646.
|
| ［14］ |
Elmas ÖF, Demirbaş A, Türsen Ü, et al. Pemphigus and COVID⁃19: Critical overview of management with a focus on treatment choice［J］. Dermatol Ther, 2020,33（6）:e14265. doi: 10.1111/dth.14265.
|
| ［15］ |
Kasperkiewicz M, Yale M, Strong R, et al. COVID⁃19 pandemic and autoimmune bullous diseases: a cross⁃sectional study of the International Pemphigus and Pemphigoid Foundation［J］. J Eur Acad Dermatol Venereol, 2021,35（7）:e418⁃e421. doi: 10.1111/jdv.17228.
|
| ［16］ |
Atarzadeh F, Daneshfard B, Dastgheib L, et al. Early description of diet⁃induced blistering skin diseases in medieval Persia: Avicenna′s point of view［J］. Skinmed, 2016,14（5）:367⁃370.
|
| ［17］ |
Kneiber D, Kowalski EH, Kridin K, et al. Gastrointestinal symptoms, gastrointestinal bleeding and the role of diet in patients with autoimmune blistering disease: a survey of the International Pemphigus and Pemphigoid Foundation［J］. J Eur Acad Dermatol Venereol, 2019,33（10）:1935⁃1940. doi: 10.1111/ jdv.15731.
|
| ［18］ |
Pedroni MN, Hirotsu C, Porro AM, et al. The role of sleep in pemphigus: a review of mechanisms and perspectives［J］. Arch Dermatol Res, 2017,309（8）:659⁃664. doi: 10.1007/s00403⁃017⁃1765⁃9.
|
| ［19］ |
Li F, Wu Y, Bian W, et al. Features and associated factors of bacterial skin infections in hospitalized patients with pemphigus: a single⁃center retrospective study［J］. Ann Clin Microbiol Antimicrob, 2020,19（1）:46. doi: 10.1186/s12941⁃020⁃00388⁃6.
|
| ［20］ |
Takahashi H, Iriki H, Mukai M, et al. Autoimmunity and immunological tolerance in autoimmune bullous diseases［J］. Int Immunol, 2019,31（7）:431⁃437. doi: 10.1093/intimm/dxz030.
|
